Le Lézard
Classified in: Business, Covid-19 virus
Subjects: SVY, ECO, TRD

Xinhua Silk Road: China-Russia (Harbin) economic and trade index report (2021) officially unveiled on Wed.

BEIJING, July 16, 2021 /CNW/ -- The China-Russia (Harbin) economic and trade index report (2021) was officially released on Wednesday in Harbin, northeast China's Heilongjiang Province.

The report, starting with the development of China-Russia trade, has accurately reflected the trade volume between China and its regions with Russia in an all-round and multi-level manner, and scientifically monitored the development level and trend of bilateral trade via the establishment of a quantifiable index system.

In 2020, China-Russia trade index maintained a stable trend and stood at 194.06 points, showed the report.

According to the report, China-Russia trade growth rate ranked first among China's major trading partners. China remained the primary trading partner of Russia, while Russia was China's 10th largest trading partner. Despite the impact of COVID-19, the two countries adhered to the principle of mutual benefit and win-win results, showing strong resilience in economic and trade cooperation.

Luan Zhicheng, Vice Mayor of Harbin, noted that Harbin will take the release of China-Russia economic and trade index as a link to comprehensively promote the practical cooperation between Harbin and Russia's Far East so as to build Harbin into an important bearing zone of all-round cooperation between China and Russia and make greater contribution to building a new highland for openness and cooperation.

The China-Russia economic and trade index quantitatively demonstrates the level and trend of China-Russia economic and trade development in a digital way, said Wu Xuejun, president assistant of China Economic Information Service (CEIS).

The index has been released for three consecutive years since its first release in 2019, Wu addressed, adding that it has become an important tool for evaluating China-Russia economic and trade development and has been highly recognized by experts in the field.

The CEIS, which is responsible for the research and development of the China-Russia economic and trade index, is one of the largest economic information service organizations in China with the widest range of service and the most comprehensive product categories. It undertakes four major information service platforms including the national financial information platform "Xinhua Finance", the Belt and Road-centered comprehensive information service platform "Xinhua Silk Road", the national credit information service platform "Xinhua Credit" and the "Xinhua Index".

Original link: https://en.imsilkroad.com/p/322699.html

SOURCE Xinhua Silk Road

These press releases may also interest you

14 jun 2024
Freed-Hardeman University conferred 377 degrees upon a talented group of students during FHU's 154th commencement exercises Saturday, May 11, 2024. In addition to the 274 bachelor's degrees, 11 associate degrees, two education specialist degrees, 81...

14 jun 2024
Today, Flag Day, the American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient organization in the nation, announced an expansion of its successful national, non-partisan voter registration and mobilization...

14 jun 2024
The global governance risk and compliance (GRC) platform market size is estimated to grow by USD 37.63 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 13.64% during the forecast period. Increased need to...

14 jun 2024
Sable Resources Ltd. ("Sable" or the "Company") announces that further to the Company's press release of May 14, 2024 on the entering into of the option agreement to acquire a 100% interest in the Perk-Rocky Project, the Company has received TSX...

14 jun 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The...

14 jun 2024
Amgen today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric...

News published on and distributed by: